Dr. Reddy's Laboratories
141 hedge funds and large institutions have $837M invested in Dr. Reddy's Laboratories in 2013 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 59 increasing their positions, 49 reducing their positions, and 19 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 49
2% less capital invested
Capital invested by funds: $854M → $837M (-$17M)
1.34% less ownership
Funds ownership: 66.53% → 65.19% (-1.3%)
5% less funds holding
Funds holding: 149 → 141 (-8)
42% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 19
44% less call options, than puts
Call options by funds: $246K | Put options by funds: $442K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$16M |
| 2 |
BG
BlackRock Group
London,
United Kingdom
|
+$10.1M |
| 3 |
Jane Street
New York
|
+$9.31M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$7.61M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
+$4.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$12.4M |
| 2 |
Morgan Stanley
New York
|
-$9.54M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
-$7.75M |
| 4 |
QBFM
QS Batterymarch Financial Management
New York
|
-$5.98M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.79M |
RDY Hedge Fund Activity: Q3 2013 in Review
141 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q3 2013, worth a combined $837M — down 2% from $854M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of RDY and 11 opened new positions — a net loss of 8 holders — while 49 trimmed existing stakes and 59 added.
The largest buyer was Fidelity International, adding an estimated $16M. The largest seller was Wellington Management Group, cutting an estimated $12.4M.
- 141 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q3 2013, down from 149 in Q2 2013.
- Funds reported $837M of Dr. Reddy's Laboratories stock for Q3 2013, down 2% quarter-over-quarter.
- 11 funds opened new Dr. Reddy's Laboratories positions in Q3 2013 and 19 closed out, a net change of -8 holders.
- The largest Dr. Reddy's Laboratories buyer in Q3 2013 was Fidelity International, an estimated $16M added.
- The largest Dr. Reddy's Laboratories seller in Q3 2013 was Wellington Management Group, an estimated $12.4M sold.
Based on aggregated 13F filings for Q3 2013.